Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gemma Medcalf

Biogen Idec building

FDA approves Biogen’s Spinraza for spinal muscular atrophy

Analysts predict blockbuster sales as drug is priced at $750,000 for first year of treatment

- PMLiVE

Behavioural marketing and its effectiveness

Marketing effectiveness is about changing behaviour. Only by understanding customer behaviour can we begin to change it.

Key accounts – origins, responsibilities and differences

Good key account managers will know more about their account status than their customers do

- PMLiVE

Ashfield Clinical appoints Nagore Fernandez Dominguez

She takes up role as head of clinical services for Europe

OncoMed’s CMO steps down

Dr Jakob Dupont to leave the clinical-stage company

- PMLiVE

What’s on the horizon?

The evolving role of the healthcare expert.

- PMLiVE

Teva hit with largest-ever fine under US anti-corruption act

Company to pay $519m after promoting Copaxone in Russia, Ukraine and Mexico

Roche Basel Switzerland

Roche’s haemophilia A drug hits targets in registration trial

Emicizumab from Japanese affiliate Chugai cleared a phase III trial

- PMLiVE

A healthy challenge

The EC’s Dr Vytenis Andriukaitis on Europe’s problems with health

Alexion Pharmaceutiacal names interim CEO and CFO

Former AZ CEO David Brennan and David Anderson join

- PMLiVE

GSK’s Deborah Waterhouse to take over from ViiV’ Dominique Limet

She will become CEO designate at the HIV-focused firm in January

- PMLiVE

J&J back in frame to buy Actelion after Sanofi talks break down

Parties now in exclusive negotiations about a possible deal

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links